COMPANY
Arbor Vita Corporation
NIH awards 18
- NIH award 9R44CA182927-05 FY2013: $961,000 awarded for that fiscal year; activity R44 (SBIR); PI SCHWEIZER, JOHANNES G; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Commercialization of the OncoE6TM Cer source ↗
- NIH award 5R43CA165442-02 FY2013: $94,891 awarded for that fiscal year; activity R43 (SBIR); PI BELMARES, MICHAEL PAUL; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Development of an HPV-E6 Cervical Neo source ↗
- NIH award 1R43CA165442-01A1 FY2012: $198,247 awarded for that fiscal year; activity R43 (SBIR); PI BELMARES, MICHAEL PAUL; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Development of an HPV-E6 Cervical source ↗
- NIH award 5R43CA153808-02 FY2011: $338,612 awarded for that fiscal year; activity R43 (SBIR); PI SCHWEIZER, JOHANNES G; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. E6 Oncoprotein Based Rapid Test for A source ↗
- NIH award 1R43CA153808-01A1 FY2010: $353,742 awarded for that fiscal year; activity R43 (SBIR); PI SCHWEIZER, JOHANNES G; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. E6 Oncoprotein Based Rapid Test for source ↗
- NIH award 5R44NS046954-03 FY2010: $859,405 awarded for that fiscal year; activity R44 (SBIR); PI LU, PETER S.; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Translation of a Novel Stroke Drug Administrat source ↗
- NIH award 5R44AI068160-04 FY2010: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SCHWEIZER, JOHANNES G; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Development of an E6 based Rapid St source ↗
- NIH award 1R43CA137935-01A2 FY2010: $208,622 awarded for that fiscal year; activity R43 (SBIR); PI BELMARES, MICHAEL PAUL; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. PDZ-targeted Therapeutics for Cerv source ↗
- NIH award 2R44NS046954-02A1 FY2009: $684,392 awarded for that fiscal year; activity R44 (SBIR); PI LU, PETER S.; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Translation of a Novel Stroke Drug Administr source ↗
- NIH award 2R44AI068160-03A1 FY2009: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI SCHWEIZER, JOHANNES G; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Development of an E6 based Rapid source ↗
- NIH award 5R44CA121155-03 FY2007: $397,454 awarded for that fiscal year; activity R44 (SBIR); PI LU, PETER S.; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. A Novel Diagnostic Assay for Oncogenic Human P source ↗
- NIH award 5R43AI068160-02 FY2007: $299,016 awarded for that fiscal year; activity R43 (SBIR); PI SCHWEIZER, JOHANNES G; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Rapid Strip Test for Cervical Cancer source ↗
- NIH award 2R44CA121155-02 FY2006: $478,244 awarded for that fiscal year; activity R44 (SBIR); PI LU, PETER S.; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. A Novel Diagnostic Assay for Oncogenic Human P source ↗
- NIH award 1R43AI068160-01 FY2006: $298,481 awarded for that fiscal year; activity R43 (SBIR); PI SCHWEIZER, JOHANNES G; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. Rapid Strip Test for Cervical Cancer source ↗
- NIH award 1R43NS046954-01A1 FY2005: $197,624 awarded for that fiscal year; activity R43 (SBIR); PI LU, PETER S.; recipient as written: ARBOR VITA CORPORATION, Fremont, CA. A Novel Drug To Reduce Neronal Damage Follow source ↗
- NIH award 1R43CA103383-01 FY2003: $189,568 awarded for that fiscal year; activity R43 (SBIR); PI LU, PETER S.; recipient as written: ARBOR VITA CORPORATION, Fremont, CA. A Novel Diagnostic for Oncogenic HPV source ↗
- NIH award 1R43CA099368-01 FY2003: $200,186 awarded for that fiscal year; activity R43 (SBIR); PI LU, PETER S.; recipient as written: ARBOR VITA CORPORATION, Fremont, CA. Prevention and Treatment of Cervical Cancer source ↗
- NIH award 1R43AI045274-01A2 FY2001: $198,318 awarded for that fiscal year; activity R43 (SBIR); PI LU, PETER S.; recipient as written: ARBOR VITA CORPORATION, FREMONT, CA. A NOVEL FAMILY OF LYMPHOCYTE ADHESION MOLECU source ↗